first edition (1980) of the Orange Book - FDA Law Blog

More documents

Recommendations

Info

APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST76LEVODOPATABLET; ORALLARODOPABD HOFFMANN-LA ROCHE Z50MG * SOOMG100MGLEVODOPA; *MULTIPLE*SEE CARBIDOPA; LEVODOPALEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDEINJECTABLE; INJECTIONARESTOCAXHE HCl WI LEVOHORDEFRrHAP CARLISLE LABS 50 UGM/Ml;2ZCARBOCAXHE HCL WI HEO-COBEFR~HAP COOK-WAITE/STERLING 50 UGM/ML;2ZXSOCAZHE HCl WI LEVOHORDEFRXHAP NOVOCOL CHEM MFG 50 UGM/Ml;ZZMEPXVACAXHE HCl WI lEVOHORDEFRXH --AP GRAHAM CHEMICAL 50 UGM/Ml;ZZLEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINEHYDROCHLORIDEINJECTABLE; INJECTIONRAVOCAINE HCL AND NOVOCAIN 101/ NEO-COBEFRINCOOK-WAITE/STERLING 50 UGM/ML;Z7.;0.47.LEVOPROPOXYPHENE NAPSYLATECAPSULE; ORALNOVRADELI LILLYEQ SOMG BASE * EQ 100MG BASESUSPENSION; ORALNOVRADELI LILLYEQ 50MG BASE/5MLLEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUMTABLET; ORALEUTHROID-lPARKE-DAVIS/W-L 60 UGM;l5 UGMEUTHROID-ZPARKE-DAVIS/W-L lZO UGMj30 UGMEUTHROID-3PARKE-DAVIS/W-L 180 UGMj45 UGMTHYROLAR-O.ZSARMOUR PHARM 12.5 UGMj3.1 UGMTHYROLAR-O .5ARMOUR PHARMZ5 UGM;6.Z5 UGMTHYROLAR-lARMOUR PHARM 50 UGM;l2.S UGMTHYROLAR-ZARMOUR PHARM 100 UGMj25 UGMTHYROLAR-3ARMOUR PHARMISO UGM;37.S UGMTHYROLAR-5ARMOUR PHARM 250 UGMj6Z.S UGMLIDOCAINELIQUID; TOPICALXYlOCAINEASTRA PHARM PRODS 57.OINTMENT; TOPICALAlPHACAIHEAT CARLISLE LABS 5ZlIDOCAXHEAT CREDO 5ZATATE FOUGERA/BYK-GULDENGRAHAM CHEMICAL570SZXYlOCAIHEAT ASTRA PHARM PRODS 570SUPPOSITORY; RECTALXYlOCAINEASTRA PHARM PRODS 100MGLEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUMTABLET; ORALEUTHROID-0.5PARKE-DAVIS/W-L 30 UGM;7.5 UGMLIDOCAINE HYDROCHLORIDEINJECTABLE; INJECTIONAlPHACA:IliE HCLAP CARLISLE LABS270
APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST,--//77LIDOCAINE HYDROCHLORIDEINJECTABLE; INJECTIONLIDOCAiNE HCLAP ABBOTT LABS 17. M 1.57. M 27.AP AM MCGAW/AM HOSP 17. M 27.AP BEL-MAR LABS 17. M 2ZAP BRISTOL LABS/BM 17. M 2Z M 47.AP CARTER-GLOGAU LABS lZ M 27.AP CUTTER LABS lZ M 2ZAP D-M PHAR~IACEUTICALS 17. M 2ZAP DELL LABS lZ M 2ZAP ELKINS-SINN/AHROBINS 0.52 M 12 M 22 M 47.AP GRAHAM CHEMICAL 22AP INT'L MEDICATION SYS 17. M 2Z M 47. M 207.AP INVENEX LABS 17. M 27. M 4ZAP L YPHO-tlED 17. M 27.AP MAURRY BIOLOGICAL 17. M 2ZAP NATCON CHEMICAL 17. M 27.AP VITARINE/WEST CHEM 17. M 1.57. M 27.AP WYETH LABS/AMHO 17. M 2ZLIDOPEHAP SURVIVAL TECHNOLOGY 102XYLOCAINEAP ASTRA PHARM PRODS 0.57. * 17. M 1.57. M 27. M 47. M 107. MAP 207.ATATATATJElLY; TOPICALLIDOCAiNE HCLINT'L MEDICATION SYS 27.XYLOCAiHEASTRA PHARM PRODS 27.SOLUTION; ORALLIDOCAiHE HCL ViSCOUSNATL PHARM MFG/B.A.RRE 27.XYLOCAIHE ~ViSCOUS~ASTRA PHARM PRODS 27.SOLUTION; TOPICALAHESTACOHAT ALCON LABS/PR 27.LARYHG-O-JET KITAT INT' L ~IEDICATION SYS 47.LTA :II: K:ITAT ABBOTT LABS 42LIDOCAINE HYDROCHLORIDESOLUTION; TOPICALPEDIATRiC LTA KZTAT ABBOTT LABS 27.XYLOCAIHEAT ASTRA PHARM PRODS 4ZLIDOCAINE HYDROCHLORIDE; *MULTIPLE*SEE DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDESEE DEXTROSE; LIDOCAINE HYDROCHLORIDESEE EPINEPHRINE; LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE'INJECTABLE; INJECTIONTERRAMYCINPFIZER LABSLINCOMYCIN HYDROCHLORIDE MONOHYDRATECAPSULE; ORALLINCOCINUPJOHNINJECTABLE; INJECTIONLINCOCINUPJOH~ISYRUP; ORALLINCOCINUPJOHNLINDANECREAM; TOPICALKWELLREED & CARNRICKLOTION; TOPICALESCABZOLAT STIEFEL LABS2X;50MG/ML * 2X;125MG/MLEQ 250MG BASE * EQ 500NG BASEEQ 300MG BASE/MLEQ 250NG BASE/5HLIX17.
Page 5:
RXD AND DRUG ACMINISTRATIONAPProVED
Page 9:
approved application, a list of app
Page 12 and 13:
products that have been approved" i
Page 14 and 15:
To assist the user in relating the
Page 16 and 17:
an evaluatien of therapeutic equiva
Page 18 and 19:
ioavailability data is required for
Page 20 and 21:
B - Drug products that FDA does not
Page 22 and 23:
and the rate of absorption.pharmace
Page 24 and 25:
4. Erythromycin stearate Tablets -
Page 27 and 28:
II. LISTINGSA. FORMAT GUIDEThis p..
Page 29 and 30:
CURRENT STATUS - POSSIBLY EFFECTIVE
Page 31 and 32:
DRUG ProDUCT EKAMPLESSingle Ingredi
Page 33 and 34:
APPROVED PRESCRIPTION DRUG PRODUCTS
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
j./APPROVED PRESCRIPTION DRUG PRODU
Page 57 and 58: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 65 and 66: -,----APPROVED PRESCRIPTION DRUG PR
Page 67 and 68: APPROVED PRESCRI~TIOHDRUG PRODUCTSD
Page 77 and 78: DIMENHYDlHNATEAPPROVED PRESCRIPTION
Page 81 and 82: ------"".,APPROVED PRESCRIPTION DRU
Page 91 and 92: APPROVED ¥RESCRIPTION DRUG PRODUCT
Page 95 and 96: '''"APPROVED PRESCRIPTION DRUG PROD
Page 97 and 98: ----..//APPROVED PRESCRIPTION DRUG
Page 107: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 125 and 126: "~''''''-- .APPROVED PRESCRIPTION D
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
PERCORTEN PIVALATE, DESOXYCORTICOST
Page 191 and 192:
Page 193 and 194:
Page 195:
oAPPROVED PRESCRIPTION DRUG PRODUCT
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
APPROVED PRESCRIPTIOH DRUG PRODUCTS
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243:
Page 246 and 247:
PRESCRIPTION DRUG PRODUCTS DEEMED A
Page 248 and 249:
Page 250 and 251:
show all

first edition (1980) of the Orange Book - FDA Law Blog

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?